Viruses and the risk of lung cancer: prevention and treatment
ERS Monograph
; 2022(98):152-162, 2022.
Artículo
en Inglés
| EMBASE | ID: covidwho-20234243
ABSTRACT
Lung cancer is the most common cancer in males and the second most common among females both in Europe and worldwide. Moreover, lung cancer is the leading cause of death due to cancer in males. The European region accounts for 23% of total cancer cases and 20% of cancer-related deaths. Relationships have been described between a number of infectious agents and cancers, but our knowledge of the role of viruses, both respiratory and systemic, in the pathogenesis of lung cancer is still rudimentary and has been poorly disseminated. In this chapter, we review the available evidence on the involvement of HPV, Epstein-Barr virus, HIV, cytomegalovirus and measles virus in the epidemiology and pathogenesis of lung cancer.Copyright © ERS 2021.
apnea hypopnea index; article; breast cancer; cancer mortality; cancer risk; CD4+ T lymphocyte; CD8+ T lymphocyte; clinical study; colon cancer; coronavirus disease 2019; Cytomegalovirus; death; Epstein Barr virus; Europe; exosome; follow up; hazard ratio; human; Human immunodeficiency virus; hyperinflammation; infectious agent; kidney cancer; lung cancer/pc [Prevention]; lung fibrosis; Measles virus; melanoma; nonhuman; obesity; oxygen saturation; pancreas cancer; pandemic; pathogenesis; phase 3 clinical trial (topic); rectum cancer; smoking; Wart virus; angiotensin converting enzyme 2/ec [Endogenous Compound]
Texto completo:
Disponible
Colección:
Bases de datos de organismos internacionales
Base de datos:
EMBASE
Tipo de estudio:
Estudio pronóstico
Idioma:
Inglés
Revista:
ERS Monograph
Año:
2022
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS